Meeting Banner
Abstract #3922

Applying 2HG MRS in glioma patients during routine clinical MRI examination

Zahra Shams1, Sarah M. Jacobs1, Jan W. Dankbaar1, Changho Choi2, Dennis W.J. Klomp1, Jannie P. Wijnen1, and Evita C. Wiegers1
1Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands, 2Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States

2HG is a valuable biomarker to detect mutational status of glioma patients. Therefore, it is of great value to be widely integrated into clinical practice. This study investigates the performance of along echo time (PRESS 97ms) 1H MRS protocol at 3Tesla to be used in routine clinical glioma imaging.

This abstract and the presentation materials are available to members only; a login is required.

Join Here